Posts tagged Madicaid.
Blogs
3 minute read
On July 7, 2016, the Centers for Medicare and Medicaid Services ("CMS") imposed several administrative penalties on Theranos, a clinical laboratory company that proposed to revolutionize the clinical laboratory business by performing multiple blood tests using a few drops of blood drawn from a finger rather than from a traditional blood draw that relies on needles and tubes. However, after inspecting the laboratory, CMS concluded that the company failed to comply with federal law and regulations governing clinical laboratories and it posed an immediate jeopardy to patient ...
Blog Editors
Recent Updates
- Podcast: Advancements of Artificial Intelligence in Health Care – One Year After White House Executive Order – Diagnosing Health Care
- Supreme Court Denies Two Certiorari Petitions on Federal Anti-Kickback Statute’s Willfulness Standard
- Importance of Negotiating Exclusivity, Expansion and Relocation Provisions in Health Care Leases
- D.C.’s Certificate of Need (CON) Process Could See Improvement with Proposed Legislation
- Exemptions from the Drug Supply Chain Security Act Enhanced Drug Distribution Security Requirements